Business Description
Zenlabs Ethica Ltd
ISIN : INE546F01013
Compare
Compare
Traded in other countries / regions
530697.India IPO Date
1995-07-05Description
Zenlabs Ethica Ltd is a pharmaceutical company engaged in the trading of pharmaceutical formulations. It manufactures and markets drugs which include GIT disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps, and anti-Bacterial drugs, nutraceuticals, and others. In addition, the group is also involved in contract manufacturing and private label manufacturing of different pharmaceutical products by manufacturing pharmaceutical products such as tablets, capsules, injections, syrups, and ointments, and covers therapeutic segments like Anti-infective, Anti-obesity, Anti-bacterial, Anti-hypertensives, Anti-fungal, Pain Killers and Nutritional Supplements for different private labels.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | 0.25 | |||||
| Debt-to-Equity | 1.47 | |||||
| Debt-to-EBITDA | 5.4 | |||||
| Interest Coverage | 1.33 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.39 | |||||
| Beneish M-Score | -1.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.3 | |||||
| 3-Year EBITDA Growth Rate | 13.5 | |||||
| 3-Year EPS without NRI Growth Rate | -18.4 | |||||
| 3-Year FCF Growth Rate | -2.7 | |||||
| 3-Year Book Growth Rate | 5.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.88 | |||||
| 9-Day RSI | 69.67 | |||||
| 14-Day RSI | 65.56 | |||||
| 6-1 Month Momentum % | -3.58 | |||||
| 12-1 Month Momentum % | 2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.32 | |||||
| Quick Ratio | 0.87 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 98.86 | |||||
| Days Sales Outstanding | 127.58 | |||||
| Days Payable | 160.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -19.16 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 26.04 | |||||
| Operating Margin % | 2.1 | |||||
| Net Margin % | 0.69 | |||||
| FCF Margin % | -15.84 | |||||
| ROE % | 4.01 | |||||
| ROA % | 0.96 | |||||
| ROIC % | 4 | |||||
| 3-Year ROIIC % | -0.8 | |||||
| ROC (Joel Greenblatt) % | 7.8 | |||||
| ROCE % | 10.74 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 74.38 | |||||
| PE Ratio without NRI | 74.38 | |||||
| Shiller PE Ratio | 46.84 | |||||
| PS Ratio | 0.51 | |||||
| PB Ratio | 2.96 | |||||
| Price-to-Tangible-Book | 2.97 | |||||
| EV-to-EBIT | 29.97 | |||||
| EV-to-EBITDA | 15.9 | |||||
| EV-to-Revenue | 0.76 | |||||
| EV-to-FCF | -4.8 | |||||
| Price-to-Graham-Number | 3.03 | |||||
| Price-to-Net-Current-Asset-Value | 5.55 | |||||
| Earnings Yield (Greenblatt) % | 3.34 | |||||
| FCF Yield % | -30.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zenlabs Ethica Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 573.534 | ||
| EPS (TTM) (₹) | 0.62 | ||
| Beta | -0.16 | ||
| Volatility % | 38.96 | ||
| 14-Day RSI | 65.56 | ||
| 14-Day ATR (₹) | 3.349921 | ||
| 20-Day SMA (₹) | 41.0945 | ||
| 12-1 Month Momentum % | 2 | ||
| 52-Week Range (₹) | 31.3 - 62.42 | ||
| Shares Outstanding (Mil) | 6.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zenlabs Ethica Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zenlabs Ethica Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zenlabs Ethica Ltd Frequently Asked Questions
What is Zenlabs Ethica Ltd(BOM:530697)'s stock price today?
The current price of BOM:530697 is ₹46.12. The 52 week high of BOM:530697 is ₹62.42 and 52 week low is ₹31.30.
When is next earnings date of Zenlabs Ethica Ltd(BOM:530697)?
The next earnings date of Zenlabs Ethica Ltd(BOM:530697) is .
Does Zenlabs Ethica Ltd(BOM:530697) pay dividends? If so, how much?
Zenlabs Ethica Ltd(BOM:530697) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers